NM_032804.6:c.493G>A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_032804.6(ADO):​c.493G>A​(p.Val165Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000355 in 1,553,310 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00037 ( 0 hom. )

Consequence

ADO
NM_032804.6 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.499

Publications

0 publications found
Variant links:
Genes affected
ADO (HGNC:23506): (2-aminoethanethiol dioxygenase) Human thiol dioxygenases include cysteine dioxygenase (CDO; MIM 603943) and cysteamine (2-aminoethanethiol) dioxygenase (ADO; EC 1.13.11.19). CDO adds 2 oxygen atoms to free cysteine, whereas ADO adds 2 oxygen atoms to free cysteamine to form hypotaurine (Dominy et al., 2007 [PubMed 17581819]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03366068).
BS2
High AC in GnomAd4 at 27 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADONM_032804.6 linkc.493G>A p.Val165Met missense_variant Exon 1 of 1 ENST00000373783.3 NP_116193.2 Q96SZ5B3KXN9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADOENST00000373783.3 linkc.493G>A p.Val165Met missense_variant Exon 1 of 1 6 NM_032804.6 ENSP00000362888.1 Q96SZ5

Frequencies

GnomAD3 genomes
AF:
0.000177
AC:
27
AN:
152198
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000368
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000202
AC:
31
AN:
153314
AF XY:
0.000228
show subpopulations
Gnomad AFR exome
AF:
0.000130
Gnomad AMR exome
AF:
0.0000401
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000758
Gnomad NFE exome
AF:
0.000466
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000375
AC:
525
AN:
1401112
Hom.:
0
Cov.:
34
AF XY:
0.000373
AC XY:
258
AN XY:
691904
show subpopulations
African (AFR)
AF:
0.0000951
AC:
3
AN:
31538
American (AMR)
AF:
0.0000831
AC:
3
AN:
36102
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25002
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36570
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79812
European-Finnish (FIN)
AF:
0.0000873
AC:
4
AN:
45816
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5678
European-Non Finnish (NFE)
AF:
0.000467
AC:
506
AN:
1082498
Other (OTH)
AF:
0.000155
AC:
9
AN:
58096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
39
78
118
157
196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152198
Hom.:
0
Cov.:
32
AF XY:
0.000148
AC XY:
11
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41458
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000368
AC:
25
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000225
Hom.:
0
Bravo
AF:
0.000208
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000237
AC:
1
ESP6500EA
AF:
0.000489
AC:
4
ExAC
AF:
0.000141
AC:
16

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 06, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.493G>A (p.V165M) alteration is located in exon 1 (coding exon 1) of the ADO gene. This alteration results from a G to A substitution at nucleotide position 493, causing the valine (V) at amino acid position 165 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
11
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0036
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.053
N
LIST_S2
Benign
0.57
T
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.034
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
-0.50
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-0.41
N
REVEL
Benign
0.17
Sift
Benign
0.064
T
Sift4G
Benign
0.062
T
Polyphen
0.95
P
Vest4
0.051
MVP
0.043
MPC
0.70
ClinPred
0.067
T
GERP RS
-8.7
Varity_R
0.064
gMVP
0.40
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202015367; hg19: chr10-64565312; API